S100B and leukemia: The potential of specific isoforms of S100 proteins as circulating biomarkers, i.e., S100A4, S100A8, S100A9, S100A12 or S100B, has already been outlined for non-hepatic diseases such as rheumatic diseases and leukemia, respectively [35,164].